Boston Scientific Gets Vein Filter OK
471001
Boston Scientific Corp. said Monday that it received Food and Drug Administration clearance to market a device designed to lower the risk of heart attacks during angioplasty and stenting procedures.
687372
A Massachusetts company received federal approval Tuesday to sell up to 4,000 artificial hearts a year, though the number of devices implanted annually will likely be far smaller.
687744
Shares of Boston Scientific (BSX:NYSE - news - research) rose Monday following the announcement that the Food and Drug Administration had approved its product to reduce the risk of a heart attack following heart bypass surgery.
423219
A device that projects an enhanced image of the underlying veins onto the skin could avoid botched injection attempts, scientists believe.
155100
Standard &amp; Poor's raised its outlook on Boston Scientific Corp. to positive from stable, citing its recovery of market share for its drug-coated Taxus cardiac stent after recalls that began in July. The debt rating agency said the upgrade reflects the Natick company's &quot;surprisingly rapid recovery&quot; of market share for Taxus, and its diverse product line. Last week, Boston Scientific ...
685438
Plagued by chronic bad news about its marquee cardiovascular products, Boston Scientific Corp. yesterday moved to shift Wall Street's focus to a strong, solidly growing part of its business: Endoscopy products used in treating everything from kidney stones to throat and digestive-tract cancers.
136747
A mesh stocking pulled up over the wide bottom of a weak heart can help it pump better and even shrink back to a more normal size, according to a study described
642261
In the past decade, artery repair has become one of the most lucrative industries in healthcare, spawning billion-dollar companies like Boston Scientific Corp. that make equipment to keep blood flowing smoothly through the body's most important vessels.
158360
The Food and Drug Administration said last night it would convene a public panel to examine the risk of blood clots in patients with drug-coated stents, among the world's most frequently implanted medical devices.
253054
A jury in Texas has ruled that Boston Scientificâs drug-coated stents infringe a 1997 patent issued to a radiologist in Princeton, N.J., and has awarded the inventor $431 million in damages, Boston Scientific said Tuesday. The suit by the patent holder, Dr. Bruce N. Saffran, did not seek to halt sales of the stents.
423009
NEW ORLEANS -- A polyester mesh stocking pulled up over the wide bottom of a weak heart can help it pump better and even shrink back to a more normal size, a study found.
354450
A U.S. judge on Thursday granted a   request from Sanofi-Aventis SASY.PA and Bristol-Myers Squibb   Co. BMY.N to block the sale of a generic form of their   top-selling Plavix blood thinner.
433995
Abiomed Inc. moved a step closer to winning federal approval for a blood pump. The Danvers company, which also makes the AbioCor artificial heart, plans to say today it has received Food and Drug Administration approval to begin a key clinical trial with 654 patients. Abiomed's Impella 2.5 Circulatory Support System is designed to temporarily help pump blood during certain ...
55879
A jury in Texas has ruled that Boston Scientificâs drug-coated stents infringed a 1997 patent issued to a radiologist and has awarded the inventor $431 million.
221602
Boston Scientific Corp. on Wednesday said US drug regulators inspected the Natick-based company&#39;s Ireland plant that makes Taxus drug-coated stents and gave the facility a clean bill of health.
56727
Boston Scientific receives European approval for its defibrillator.
228027
The device, which called a &quot;vein contrast enhancer,&quot; uses a near-infrared camera to capture a image of the patient&#39;s veins.